Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 164

1.

[Cholesterol inhibitor and memantine in symptomatic dementia therapy].

Rodda J, Carter J.

Praxis (Bern 1994). 2013 Feb 27;102(5):293-300; discussion 298-9. doi: 10.1024/1661-8157/a001209. Review. German. No abstract available.

PMID:
23446240
2.

Cholinesterase inhibitors in the treatment of Alzheimer's disease and related dementias.

Masterman D.

Clin Geriatr Med. 2004 Feb;20(1):59-68. No abstract available.

PMID:
15062487
3.

Long-term effects of the concomitant use of memantine with cholinesterase inhibition in Alzheimer disease.

Lopez OL, Becker JT, Wahed AS, Saxton J, Sweet RA, Wolk DA, Klunk W, Dekosky ST.

J Neurol Neurosurg Psychiatry. 2009 Jun;80(6):600-7. doi: 10.1136/jnnp.2008.158964. Epub 2009 Feb 9. Erratum in: J Neurol Neurosurg Psychiatry. 2009 Sep 1;80(9):1056.

4.

Weight-loss associated with anti-dementia drugs in a patient with Parkinson's disease.

Gallini A, Sommet A, Salandini AM, Veyssière P, Montastruc JL, Montastruc JL.

Mov Disord. 2007 Oct 15;22(13):1980-1. No abstract available.

PMID:
17657810
5.

Treatment of Alzheimer disease.

Winslow BT, Onysko MK, Stob CM, Hazlewood KA.

Am Fam Physician. 2011 Jun 15;83(12):1403-12. Erratum in: Am Fam Physician. 2014 Aug 15;90(4):209.

6.

[Medical treatment of Alzheimer's disease].

Johannsen P.

Ugeskr Laeger. 2006 Oct 2;168(40):3424-9. Review. Danish.

PMID:
17032609
7.

[Dementia].

Diehl RR.

Fortschr Neurol Psychiatr. 2003 Nov;71(11):617-28. Review. German. No abstract available.

PMID:
14608514
8.

[Modern therapy for dementia].

Padberg F, Möller HJ, Bottlender R, Hampel H.

MMW Fortschr Med. 2005 May 17;147 Spec No 2:71-4, 76-7. German.

PMID:
15968877
9.

Rationale for combination therapy with galantamine and memantine in Alzheimer's disease.

Grossberg GT, Edwards KR, Zhao Q.

J Clin Pharmacol. 2006 Jul;46(7 Suppl 1):17S-26S. Review.

PMID:
16809811
10.

Memantine: a new approach to Alzheimer's disease.

Keltner NL, Williams B.

Perspect Psychiatr Care. 2004 Jul-Sep;40(3):123-4. No abstract available.

PMID:
15515294
11.

Antidementia drug use among community-dwelling individuals with Alzheimer's disease in Finland: a nationwide register-based study.

Taipale H, Tanskanen A, Koponen M, Tolppanen AM, Tiihonen J, Hartikainen S.

Int Clin Psychopharmacol. 2014 Jul;29(4):216-23. doi: 10.1097/YIC.0000000000000032.

12.

Alternative drug therapies for dementia.

Howland RH.

J Psychosoc Nurs Ment Health Serv. 2011 May;49(5):17-20. doi: 10.3928/02793695-20110407-03. Epub 2011 Apr 27.

PMID:
21553703
13.

A review comparing the safety and tolerability of memantine with the acetylcholinesterase inhibitors.

Jones RW.

Int J Geriatr Psychiatry. 2010 Jun;25(6):547-53. doi: 10.1002/gps.2384. Review.

PMID:
20049770
14.

Clinical practice with anti-dementia drugs: a consensus statement from British Association for Psychopharmacology.

Burns A, O'Brien J; BAP Dementia Consensus group, Auriacombe S, Ballard C, Broich K, Bullock R, Feldman H, Ford G, Knapp M, McCaddon A, Iliffe S, Jacova C, Jones R, Lennon S, McKeith I, Orgogozo JM, Purandare N, Richardson M, Ritchie C, Thomas A, Warner J, Wilcock G, Wilkinson D; British Association for Psychopharmacology.

J Psychopharmacol. 2006 Nov;20(6):732-55. Review.

PMID:
17060346
15.

Memantine in the treatment of dementia.

Maggiore C, Locatelli L, Grandi FC, Pizzolato G; Cochrane Neurological Network.

Neuroepidemiology. 2007;28(2):118-9. Epub 2007 Apr 4. No abstract available.

PMID:
17409774
16.

Memantine (Ebixa) in clinical practice - results of an observational study.

Calabrese P, Essner U, Forstl H.

Dement Geriatr Cogn Disord. 2007;24(2):111-7. Epub 2007 Jun 29.

17.

[Antidementia drugs].

Müller-Spahn F, Sollberger D, Wollmer MA.

Ther Umsch. 2009 Jun;66(6):432-40. doi: 10.1024/0040-5930.66.6.432. Review. German.

PMID:
19496039
18.

What is the rationale for new treatment strategies in Alzheimer's disease?

Rogawski MA.

CNS Spectr. 2004 Jul;9(7 Suppl 5):6-12.

PMID:
15241294
19.

[Early treatment with anti-dementia drugs when possible. These signs reveal Alzheimer disease].

[No authors listed]

MMW Fortschr Med. 2003 Jun 5;145(23):60. German. No abstract available.

PMID:
12854234
20.

[The use of galantamine in Alzheimer's disease associated with vascular dementia (according to the study of T. Erkinjuntti group)].

Damulin IV.

Zh Nevrol Psikhiatr Im S S Korsakova. 2009;109(5):65-7. Russian. No abstract available.

PMID:
19938276

Supplemental Content

Support Center